New Synergistic Combination Therapy of Mupirocin and α-Pinene Against Multidrug-Resistant Clinical Strains of

Paulo Cáceres-Guido1, Nicolás Martín-Vázquez2, Adriana Ojeda-Sana3

  • 1Pharmacokinetics and Clinical Pharmacology Research Unit, Pharmacy - Integrative Medicine Group, Hospital de Pediatría Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina.

Abstract

Insights

Rosemary

Area of Science:

  • Phytochemistry
  • Microbiology
  • Pharmacology

Background:

  • Increased mupirocin use drives resistance in methicillin-resistant Staphylococcus aureus (MRSA).
  • MRSA infections lead to prolonged hospital stays and significant healthcare costs.
  • Alternative treatments are needed to combat multidrug-resistant MRSA strains.

Purpose of the Study:

  • To evaluate the antimicrobial activity of Salvia rosmarinus (rosemary) compounds against multidrug-resistant MRSA.
  • To investigate the synergistic effects of rosemary constituents with mupirocin.
  • To assess the efficacy and safety of a combined topical formulation in an in vivo model.

Main Methods:

  • In vitro testing of α-pinene (α-Pi) and mupirocin using MIC, MBC, and FICI.
  • In vivo efficacy study using a mouse model of MRSA-infected wounds.
  • Assessment of skin toxicity in mice and rabbits for topical formulations.

Main Results:

  • α-Pinene demonstrated in vitro and in vivo activity against MRSA.
  • Synergistic antimicrobial activity was observed between α-Pi and mupirocin.
  • A topical formulation of α-Pi and mupirocin enhanced MRSA eradication in vivo without significant toxicity.

Conclusions:

  • A topical formulation combining mupirocin and α-pinene shows potential for treating MRSA infections.
  • This combination may offer an innovative approach to overcome mupirocin resistance.
  • Further development could lead to new therapeutic agents against resistant bacterial strains.